Skip to content
Rglax Pharma

Export region

Tablet coating material exported to North America

US FDA oversight, USP-NF specifications and Drug Master File referencing.

What this region runs

We supply into the United States, and US and Canadian oral solid manufacture works to USP-NF excipient monographs. Finished product applications commonly reference a Drug Master File for a coating system rather than restating the formulation, which is why the DMF question comes up early here and rarely anywhere else.

Why our range fits it

Our U.S.-DMF is applied for rather than granted, and we will not describe it as anything else. If you are evaluating us for a North American application, that is the first thing to establish, and we would rather you know it before you spend time on a technical evaluation.

What to send us

Tell us the application stage you are at and whether DMF reference is a requirement for your submission. We will give you the current status in writing.

Market facts

Markets
United States, Canada
Pharmacopoeia
USP-NF, with excipient monographs in the National Formulary.
Exported from
Plot No. 30, Industrial Area Tahliwal, Himachal Pradesh, India
Compliance
WHO-GMP Compliance Unit

Regulators you would be working under

  • US FDA
  • Health Canada

Listed so you know the framework we would be supplying into. It is not a claim that we hold a registration or approval with any of them.

What ships to North America

Tablets coated on our own pan at Tahliwal. Shade is matched against a retained sample you send us, not against a colour code.

  • Metallic blue coated tablets beside an Rglax DB3012 coating dispersion

    Metallic blue DB3012

  • Orange film coated caplets with a break line

    Aqueous colour film coat

  • White film coated round tablets

    Extra white film coat

  • Metallic blue round coated tablets

    Pearl and metallic finish

Call usWhatsApp